Breccia, M <br/><br/>
5'-azacitidine in myelodysplastic syndromes with inversion of chromosome 3.  [electronic resource] 

 -  Leukemia  Apr 2011 
 - 736-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2011.6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Azacitidine--therapeutic use<br/>Chromosome Inversion--genetics<br/>Chromosomes, Human, Pair 3--genetics<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--drug therapy<br/>Treatment Outcome